Client Specific Prospective Sera Collections:
Bay State Biologicals collaborates with FDA Licensed Blood Donor Centers, HealthCare Groups, Local Hospitals, Multiple Out Reach Centers, Thirty Nursing Homes, and a network of dedicated physicians eager to participate in promising new research projects that could potentially benefit patient care and outcomes. Clinical Regulatory Services are available to develop the required Protocol/IICF documents for submission to local and central IRB's prior to initiating prospective patient studies/enrolments. After receiving written confirmation from the IRB of acceptance of both protocol and IICF Bay State Biologicals will initiate the approved site/s, monitor and audit site/s while providing regular updates to sponsors ending with close out of the project.